Is Cannabis of Potential Value as a Therapeutic for Inflammatory Bowel Disease?

被引：0
|
作者：
Timna Naftali
机构：
[1] Meir Hospital Sapir Medical Center,Institute of Gastroenterology and Hepatology
[2] Tel Aviv University,The Sackler School of Medicine
来源：
Digestive Diseases and Sciences | 2019年 / 64卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2696 / 2698
页数：2
相关论文
共 50 条
  • [31] Stem Cells in Inflammatory Bowel Disease: New Potential Therapeutic Target
    Song, In Hwan
    Jang, Byung Ik
    INTESTINAL RESEARCH, 2013, 11 (02) : 79 - 84
  • [32] Polyoxometalate nanoclusters: A potential preventative and therapeutic drug for inflammatory bowel disease
    Wang, Jingguo
    Tao, Zhenchao
    Tian, Tian
    Qiu, Jun
    Qian, Haisheng
    Zha, Zhengbao
    Miao, Zhaohua
    Ma, Yan
    Wang, Hua
    CHEMICAL ENGINEERING JOURNAL, 2021, 416
  • [33] Cannabis and Its Potential Protective Role Against Inflammatory Bowel Disease: A Scoping Review
    Nso, Nso
    Nyabera, Akwe
    Nassar, Mahmoud
    Alshamam, Mohsen S.
    Sumbly, Vikram
    Vest, Mallorie
    Patel, Nehal
    Ojong, Gilbert
    Rizzo, Vincent
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [34] META-ANAYSIS OF THE THERAPEUTIC IMPACT OF CANNABIS AND CANNABINOID-DERIVATIVES IN INFLAMMATORY BOWEL DISEASE
    Kang, Hansol
    Schmoyer, Christopher
    Weiss, Alexandra
    Lewis, James D.
    GASTROENTEROLOGY, 2024, 166 (05) : S812 - S812
  • [35] ASSESSMENT OF THERAPEUTIC VALUE OF AN ELEMENTAL DIET IN CHRONIC INFLAMMATORY BOWEL-DISEASE
    AXELSSON, C
    JARNUM, S
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1977, 12 (01) : 89 - 95
  • [36] Therapeutic targets in inflammatory bowel disease
    Fluxa, Daniela
    Abreu, Maria T.
    REVISTA MEDICA CLINICA LAS CONDES, 2019, 30 (04): : 315 - 322
  • [37] Therapeutic peptides in inflammatory bowel disease
    Herrlinger, Klaus R.
    Stange, Eduard F.
    Fellermann, Klaus
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (04) : 455 - 466
  • [38] Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians
    Megan C. Buckley
    Anand Kumar
    Arun Swaminath
    Advances in Therapy, 2021, 38 : 4152 - 4161
  • [39] THE PREVALENCE AND USE OF CANNABIS BY PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Du, Lillian
    Deshpande, Amol
    Yang, Laura
    Boguslavsky, Shlomit
    Croitoru, Kenneth
    Gallinger, Zane
    Huang, Vivian
    Silverberg, Mark S.
    Weizman, Adam V.
    Nguyen, Geoffrey C.
    Steinhart, A. Hillary
    GASTROENTEROLOGY, 2019, 156 (06) : S27 - S28
  • [40] Therapeutic leukocytapheresis for inflammatory bowel disease
    Saniabadi, Abbi R.
    Hanai, Hiroyuki
    Fukunaga, Ken
    Sawada, Koji
    Shima, Chikako
    Bjarnason, Ingvar
    Lofberg, Robert
    TRANSFUSION AND APHERESIS SCIENCE, 2007, 37 (02) : 191 - 200
12345